{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T06:10:52Z","timestamp":1651644652915},"reference-count":56,"publisher":"Akademiai Kiado Zrt.","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Orvosi Hetilap"],"published-print":{"date-parts":[[2015,4]]},"abstract":"As the result of various harmful effects (infectious agents, metabolic diseases, unhealthy diet, obesity, toxic agents, autoimmune processes) hepatic damage may develop, which can progress towards liver steatosis, and fibrosis as well. The most common etiological factors of liver damages are hepatitis B and C infection, alcohol consumption and non-alcoholic fatty liver disease. Liver biopsy is considered as the gold standard for the diagnosis of chronic liver diseases. Due to the dangers and complications of liver biopsy, studies are focused on non-invasive markers and radiological imaging for liver steatosis, progression of fatty liver, activity of the necroinflammation and the severity of the fibrosis. Authors review the possibilities of non-invasive assessment of liver steatosis. The statistical features of the probes (positive, negative predictive values, sensitivity, specificity) are reviewed. The role of radiological imaging is also discussed. Although the non-invasive methods discussed in this article are useful to assess liver steatosis, further studies are needed to validate to follow progression of the diseases and to control therapeutic response. Orv. Hetil., 2015, 156(14), 543\u2013551.<\/jats:p>","DOI":"10.1556\/oh.2015.30123","type":"journal-article","created":{"date-parts":[[2015,3,30]],"date-time":"2015-03-30T01:01:28Z","timestamp":1427677288000},"page":"543-551","source":"Crossref","is-referenced-by-count":2,"title":["Non-invasive assessment of fatty liver"],"prefix":"10.1556","volume":"156","author":[{"given":"Anna","family":"Egresi","sequence":"first","affiliation":[{"name":"Semmelweis Egyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar II. Belgy\u00f3gy\u00e1szati Klinika Budapest Szentkir\u00e1lyi u. 46. 1088"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Lengyel","sequence":"additional","affiliation":[{"name":"Semmelweis Egyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar II. Belgy\u00f3gy\u00e1szati Klinika Budapest Szentkir\u00e1lyi u. 46. 1088"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krisztina","family":"Hagym\u00e1si","sequence":"additional","affiliation":[{"name":"Semmelweis Egyetem, \u00c1ltal\u00e1nos Orvostudom\u00e1nyi Kar II. Belgy\u00f3gy\u00e1szati Klinika Budapest Szentkir\u00e1lyi u. 46. 1088"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"1","unstructured":"Bedogni, G., Nobili, V., Tiribelli, C.:<\/i> Epidemiology of fatty liver: an update. World J. Gastroenterol., 2014, 20<\/i>(27), 9050\u20139054."},{"key":"2","doi-asserted-by":"crossref","unstructured":"Weiss, J., Rau, M., Geier, A.:<\/i> Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment. Dtsch. Arztebl. Int., 2014, 111<\/i>(26), 447\u2013452.","DOI":"10.3238\/arztebl.2014.0447"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Persico, M., Iolascon, A.:<\/i> Steatosis as a co-factor in chronic liver diseases. World J. Gastroenterol., 2010, 16<\/i>(10), 1171\u20131176.","DOI":"10.3748\/wjg.v16.i10.1171"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Usluer, G., Erben, N., Aykin, N., et al.:<\/i> Comparison of non-invasive fibrosis markers and classical liver biopsy in chronic hepatitis C. Eur. J. Clin. Microbiol. Infect. Dis., 2012, 31<\/i>(8), 1873\u20131878.","DOI":"10.1007\/s10096-011-1513-6"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Michielsen, P. P., Francque, S. M., van Dongen, J. L.:<\/i> Viral hepatitis and hepatocellular carcinoma. World J. Surg. Oncol., 2005, 3<\/i>, 27.","DOI":"10.1186\/1477-7819-3-27"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Hunyady, B., Gervain, J., Horv\u00e1th, G., et al.:<\/i> Diagnosis, treatment, and follow-up of hepatitis C-virus related liver disease. Hungarian national consensus guideline. [A C-v\u00edrus hepatitis diagnosztik\u00e1ja, antivir\u00e1lis kezel\u00e9se, kezel\u00e9s ut\u00e1ni gondoz\u00e1sa. Magyar konszenzusaj\u00e1nl\u00e1s.] Orv. Hetil., 2014, 155<\/i> (Suppl. 2), 3\u201324. [Hungarian]","DOI":"10.1556\/OH.2013.29893"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Lakatos, M., Hagym\u00e1si, K., Lengyel, G.:<\/i> Fatty liver and hepatitis C virus infection. [A m\u00e1jzs\u00edrosod\u00e1s \u00e9s a hepatitis C-v\u00edrus-fert\u0151z\u00e9s.] Orv. Hetil., 2011, 152<\/i>(38), 1513\u20131519. [Hungarian]","DOI":"10.1556\/OH.2011.29209"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Horv\u00e1th, G., Hunyady, B., Gervain, J., et al.:<\/i> Diagnosis and treatment of chronic hepatitis B and D. Hungarian national consensus guideline. [A B- \u00e9s D-v\u00edrus hepatitis diagnosztik\u00e1ja, antivir\u00e1lis kezel\u00e9se. Magyar konszenzusaj\u00e1nl\u00e1s.] Orv. Hetil., 2014, 155<\/i> (Suppl. 2), 25\u201336. [Hungarian]","DOI":"10.1556\/OH.2015.30331"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Zheng, R. D., Chen, J. N., Zhuang, Q. Y., et al.:<\/i> Clinical and virological characteristics of chronic hepatitis B patients with hepatic steatosis. Int. J. Med. Sci., 2013, 10<\/i>(5), 641\u2013646.","DOI":"10.7150\/ijms.5649"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Rastogi, A., Sakhuja, P., Kumar, A., et al.:<\/i> Steatosis in chronic hepatitis B: prevalence and correlation with biochemical, histologic, viral, and metabolic parameters. Indian J. Pathol. Microbiol., 2011, 54<\/i>(3), 454\u2013459.","DOI":"10.4103\/0377-4929.85074"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Altlparmak, E., Koklu, S., Yalinkilic, M., et al.:<\/i> Viral and host causes of fatty liver in chronic hepatitis B. World J. Gastroenterol., 2005, 11<\/i>(20), 3056\u20133059.","DOI":"10.3748\/wjg.v11.i20.3056"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Torruellas, C., French, S. W., Medici, V.:<\/i> Diagnosis of alcoholic liver disease. World J. Gastroenterol., 2014, 20<\/i>(33), 11684\u201311699.","DOI":"10.3748\/wjg.v20.i33.11684"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Seth, D., Haber, P. S., Syn, W. K., et al.:<\/i> Pathogenesis of alcohol-induced liver disease: classical concepts and recent advances. J. Gastroenterol. Hepatol., 2011, 26<\/i>(7), 1089\u20131105.","DOI":"10.1111\/j.1440-1746.2011.06756.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Sakhuja, P.:<\/i> Pathology of alcoholic liver disease, can it be differentiated from nonalcoholic steatohepatitis? World J. Gastroenterol., 2014, 20<\/i>(44), 16474\u201316479.","DOI":"10.3748\/wjg.v20.i44.16474"},{"key":"15","unstructured":"Hagym\u00e1si, K., Lengyel, G., Tulassay, Zs.:<\/i> Non-alcoholic fatty liver in 2013. [A nem alkoholos zs\u00edrm\u00e1j betegs\u00e9gr\u0151l 2013-ban.] Magyar Belorvosi Arch\u00edvum, 2013, 66<\/i>(4), 185\u2013191. [Hungarian]"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Chalasani, N., Younossi, Z., Lavine, J. E., et al.:<\/i> The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology, 2012, 55<\/i>(6), 2005\u20132023.","DOI":"10.1002\/hep.25762"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Giorgio, V., Prono, F., Graziano, F., et al.:<\/i> Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets. BMC Pediatr., 2013, 13<\/i>, 40.","DOI":"10.1186\/1471-2431-13-40"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Hagym\u00e1si, K., Lengyel, G.:<\/i> Non-alcoholic steatosis\/steatohepatitis \u2013 2010. [Nem alkoholos steatosis\/steatohepatitis \u2013 2010.] Orv. Hetil., 2010, 151<\/i>(47), 1940\u20131945. [Hungarian]","DOI":"10.1556\/OH.2010.28989"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Gusdon, A. M., Song, K. X., Qu, S.:<\/i> Nonalcoholic fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspective. Oxid. Med. Cell. Longev., 2014, 2014,<\/i> 637027.","DOI":"10.1155\/2014\/637027"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Hue, L., Rider, M. H.:<\/i> The AMP-activated protein kinase: more than an energy sensor. Essays Biochem., 2007, 43<\/i>, 121\u2013137.","DOI":"10.1042\/bse0430121"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Nakamura, M. T., Yudell, B. E., Loor, J. J.:<\/i> Regulation of energy metabolism by long-chain fatty acids. Prog. Lipid Res., 2014, 53,<\/i> 124\u2013144.","DOI":"10.1016\/j.plipres.2013.12.001"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Joseph, S. B., Laffitte, B. A., Patel, P. H., et al.:<\/i> Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J. Biol. Chem., 2002, 277<\/i>(13), 11019\u201311025.","DOI":"10.1074\/jbc.M111041200"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Lefebvre, P., Cariou, B., Lien, F., et al.:<\/i> Role of bile acids and bile acid receptors in metabolic regulation. Physiol. Rev., 2009, 89<\/i>(1), 147\u2013191.","DOI":"10.1152\/physrev.00010.2008"},{"key":"24","unstructured":"Rustagi, T., Newton, E., Kar, P.:<\/i> Percutaneous liver biopsy. Trop. Gastroenterol., 2010, 31<\/i>(3), 199\u2013212."},{"key":"25","doi-asserted-by":"crossref","unstructured":"Schaff, Zs.:<\/i> The value of liver biopsy in chronic hepatitis. [A m\u00e1jbiopszia \u00e9rt\u00e9ke kr\u00f3nikus hepatitisben.] Orv. Hetil., 2011, 152<\/i>(22), 856\u2013858. [Hungarian]","DOI":"10.1556\/OH.2011.29126"},{"key":"26","unstructured":"Nalbantoglu, I. L., Brunt, E. M.:<\/i> Role of liver biopsy in nonalcoholic fatty liver disease. World J. Gastroenterol., 2014, 20<\/i>(27), 9026\u20139037."},{"key":"27","doi-asserted-by":"crossref","unstructured":"Ferraioli, G., Tinelli, C., Lissandrin, R., et al.:<\/i> Controlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis. World J. Gastroenterol., 2014, 20<\/i>(21), 6626\u20136631.","DOI":"10.3748\/wjg.v20.i21.6626"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Alkhouri, N., De Vito, R., Alisi, A., et al.:<\/i> Development and validation of a new histological score for pediatric non-alcoholic fatty liver disease. J. Hepatol., 2012, 57<\/i>(6), 1312\u20131318.","DOI":"10.1016\/j.jhep.2012.07.027"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Bedossa, P., Poitou, C., Veyrie, N., et al.:<\/i> Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology, 2012, 56<\/i>(5), 1751\u20131759.","DOI":"10.1002\/hep.25889"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Sebastiani, G., Halfon, P., Castera, L., et al.:<\/i> SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C. Hepatology, 2009, 49<\/i>(6), 1821\u20131827.","DOI":"10.1002\/hep.22859"},{"key":"31","unstructured":"Papastergiou, V., Tsochatzis, E., Burroughs, A. K.:<\/i> Non-invasive assessment of liver fibrosis. Ann. Gastroenterol., 2012, 25<\/i>(3), 218\u2013231."},{"key":"32","doi-asserted-by":"crossref","unstructured":"Fitzpatrick, E., Dhawan, A.:<\/i> Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future. World J. Gastroenterol., 2014, 20<\/i>(31), 10851\u201310863.","DOI":"10.3748\/wjg.v20.i31.10851"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Kotronen, A., Peltonen, M., Hakkarainen, A., et al.:<\/i> Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology, 2009, 137<\/i>(3), 865\u2013872.","DOI":"10.1053\/j.gastro.2009.06.005"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Kahl, S., Strassburger, K., Nowotny, B., et al.:<\/i> Comparison of liver fat indices for the diagnosis of hepatic steatosis and insulin resistance. PLoS ONE, 2014, 9<\/i>(4), e94059.","DOI":"10.1371\/journal.pone.0094059"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Lee, J. H., Kim, D., Kim, H. J., et al.:<\/i> Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig. Liver Dis., 2010, 42<\/i>(7), 503\u2013508.","DOI":"10.1016\/j.dld.2009.08.002"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Bedogni, G., Bellentani, S., Miglioli, L., et al.:<\/i> The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol., 2006, 6<\/i>, 33.","DOI":"10.1186\/1471-230X-6-33"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Zelber-Sagi, S., Webb, M., Assy, N., et al.:<\/i> Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification. World J. Gastroenterol., 2013, 19<\/i>(1), 57\u201364.","DOI":"10.3748\/wjg.v19.i1.57"},{"key":"38","unstructured":"Angin, Y., Arslan, N., Kuralay, F.:<\/i> Leptin-to-adiponectin ratio in obese adolescents with nonalcoholic fatty liver disease. Turk. J. Pediatr., 2014, 56<\/i>(3), 259\u2013266."},{"key":"39","doi-asserted-by":"crossref","unstructured":"Pagano, C., Soardo, G., Pilon, C., et al.:<\/i> Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. J. Clin. Endocrinol. Metab., 2006, 91<\/i>(3), 1081\u20131086.","DOI":"10.1210\/jc.2005-1056"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Diab, D. L., Yerian, L., Schauer, P., et al.:<\/i> Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients. Clin. Gastroenterol. Hepatol., 2008, 6<\/i>(11), 1249\u20131254.","DOI":"10.1016\/j.cgh.2008.07.016"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Younossi, Z. M., Page, S., Rafiq, N., et al.:<\/i> A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis. Obes. Surg., 2011, 21<\/i>(4), 431\u2013439.","DOI":"10.1007\/s11695-010-0204-1"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Feldstein, A. E., Alkhouri, N., De Vito, R., et al.:<\/i> Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in children. Am. J. Gastroenterol., 2013, 108<\/i>(9), 1526\u20131531.","DOI":"10.1038\/ajg.2013.168"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Yesilova, Z., Yaman, H., Oktenli, C., et al.:<\/i> Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease. Am. J. Gastroenterol., 2005, 100<\/i>(4), 850\u2013855.","DOI":"10.1111\/j.1572-0241.2005.41500.x"},{"key":"44","doi-asserted-by":"crossref","unstructured":"Chalasani, N., Deeg, M. A., Crabb, D. W.:<\/i> Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am. J. Gastroenterol., 2004, 99<\/i>(8), 1497\u20131502.","DOI":"10.1111\/j.1572-0241.2004.30159.x"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Egresi, A., Lengyel, G., Hagym\u00e1si, K.:<\/i> Options of non-invasive assessment of liver fibrosis based on the clinical data. [A m\u00e1jfibrosis nem invaz\u00edv jellemz\u00e9s\u00e9nek lehet\u0151s\u00e9gei a klinikai adatok t\u00fckr\u00e9ben.] Orv. Hetil., 2015, 156<\/i>(2), 43\u201352. [Hungarian]","DOI":"10.1556\/OH.2015.30069"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Poynard, T., Lassailly, G., Diaz, E., et al.:<\/i> Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data. PLoS ONE, 2012, 7<\/i>(3), e30325.","DOI":"10.1371\/journal.pone.0030325"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Ratziu, V., Giral, P., Muntenau, M., et al.:<\/i> Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemia. Aliment. Pharmacol. Ther., 2007, 25<\/i>(2), 207\u2013218.","DOI":"10.1111\/j.1365-2036.2006.03182.x"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Lee, S. S., Park, S. H.:<\/i> Radiologic evaluation of nonalcoholic fatty liver disease. World J. Gastroenterol., 2014, 20<\/i>(23), 7392\u20137402.","DOI":"10.3748\/wjg.v20.i23.7392"},{"key":"49","doi-asserted-by":"crossref","unstructured":"Lee, S. S., Park, S. H., Kim, H. J., et al.:<\/i> Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J. Hepatol., 2010, 52<\/i>(4), 579\u2013585.","DOI":"10.1016\/j.jhep.2010.01.008"},{"key":"50","doi-asserted-by":"crossref","unstructured":"Saadeh, S., Younossi, Z. M., Remer, E. M., et al.:<\/i> The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology, 2002, 123<\/i>(3), 745\u2013750.","DOI":"10.1053\/gast.2002.35354"},{"key":"51","doi-asserted-by":"crossref","unstructured":"De Moura Almeida, A., Cotrim, H. P., Barbosa, D. B., et al.:<\/i> Fatty liver disease in severe obese patients: diagnostic value of abdominal ultrasound. World J. Gastroenterol., 2008, 14<\/i>(9), 1415\u20131418.","DOI":"10.3748\/wjg.14.1415"},{"key":"52","doi-asserted-by":"crossref","unstructured":"Zhang, B., Ding, F., Chen, T., et al.:<\/i> Ultrasound hepatic\/renal ratio and hepatic attenuation rate for quantifying liver fat content. World J. Gastroenterol., 2014, 20<\/i>(47), 17985\u201317992.","DOI":"10.3748\/wjg.v20.i47.17985"},{"key":"53","doi-asserted-by":"crossref","unstructured":"Lup\u0219or-Platon, M., Stef\u0103nescu, H., Mure\u0219an, D., et al.:<\/i> Noninvasive assessment of liver steatosis using ultrasound methods. Med. Ultrason., 2014, 16<\/i>(3), 236\u2013245.","DOI":"10.11152\/mu.2013.2066.163.1mlp"},{"key":"54","doi-asserted-by":"crossref","unstructured":"Shi, K. Q., Tang, J. Z., Zhu, X. L., et al.:<\/i> Controlled attenuation parameter for the detection of steatosis severity in chronic liver disease: a meta-analysis of diagnostic accuracy. J. Gastroenterol. Hepatol., 2014, 29<\/i>(6), 1149\u20131158.","DOI":"10.1111\/jgh.12519"},{"key":"55","doi-asserted-by":"crossref","unstructured":"Van Werven, J. R., Marsman, H. A., Nederveen, A. J., et al.:<\/i> Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology, 2010, 256<\/i>(1), 159\u2013168.","DOI":"10.1148\/radiol.10091790"},{"key":"56","doi-asserted-by":"crossref","unstructured":"T\u00e1rnoki, \u00c1. D., T\u00e1rnoki, D. L., Karlinger, K., et al.:<\/i> Nonalcoholic fatty liver disease: implications for the radiologist. [A nem alkoholos zs\u00edrm\u00e1j h\u00e1ttere \u00e9s radiol\u00f3giai vonatkoz\u00e1sai.] Magyar Radiol\u00f3gia Online, 2013, 4<\/i>(4). [Hungarian]","DOI":"10.5374\/mro.2013.04.02"}],"container-title":["Orvosi Hetilap"],"original-title":[],"language":"hu","link":[{"URL":"https:\/\/www.akademiai.com\/doi\/pdf\/10.1556\/OH.2015.30123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:43:00Z","timestamp":1651624980000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/doi\/10.1556\/oh.2015.30123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":56,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["10.1556\/OH.2015.30123"],"URL":"https:\/\/doi.org\/10.1556\/oh.2015.30123","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}